A core part of CTRad’s work is to support the development of radiotherapy research proposals.
There are two main ways that CTRad can do to help:
RADCAS is a year-round advisory service for trial proposals
Submit ideas and gain face-to-face feedback
Other ways CTRad supports research are:
A collaborative network working in partnership with industry and funders to progress preclinical radiotherapy-drug combinations.
A network to help researchers develop strong biomarker-based translational components for radiotherapy studies.
The NCRI RTTQA team provides advice to help setup trials that include radiotherapy components.
Patient, carers and others affected by cancer are key contributors to our work.